All terms in UBERON

Label Id Description
positive regulation of muscle cell apoptotic process GO_0010661 [Any process that increases the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.]
negative regulation of striated muscle cell apoptotic process GO_0010664 [Any process that decreases the rate or extent of striated muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a striated muscle cell and result in its death.]
regulation of cardiac muscle cell apoptotic process GO_0010665 [Any process that modulates the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.]
actin filament organization GO_0007015 [A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking.]
microtubule-based process GO_0007017 [Any cellular process that depends upon or alters the microtubule cytoskeleton, that part of the cytoskeleton comprising microtubules and their associated proteins.]
protein depolymerization GO_0051261 [The process in which protein polymers, compounds composed of a large number of component monomers, are broken down. Depolymerization occurs by the successive removal of monomers from an existing poly- or oligomeric protein.]
positive regulation of cardiac muscle cell apoptotic process GO_0010666 [Any process that increases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.]
negative regulation of cardiac muscle cell apoptotic process GO_0010667 [Any process that decreases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.]
ectodermal cell differentiation GO_0010668 [The process in which relatively unspecialized cells acquire specialized structural and/or functional features of an ectodermal cell. Differentiation includes the processes involved in commitment of a cell to a specific fate.]
microtubule nucleation GO_0007020 [The process in which tubulin alpha-beta heterodimers begin aggregation to form an oligomeric tubulin structure (a microtubule seed). Microtubule nucleation is the initiating step in the formation of a microtubule in the absence of any existing microtubules ('de novo' microtubule formation).]
microtubule cytoskeleton organization GO_0000226 [A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.]
negative regulation of axonemal microtubule depolymerization GO_0007027 [Any process that stops, prevents, or reduces the frequency, rate or extent of the depolymerization of the specialized microtubules of the axoneme.]
negative regulation of microtubule depolymerization GO_0007026 [Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.]
negative regulation of protein depolymerization GO_1901880 [Any process that stops, prevents or reduces the frequency, rate or extent of protein depolymerization.]
negative regulation of microtubule polymerization or depolymerization GO_0031111 [Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule polymerization or depolymerization.]
cytoplasm organization GO_0007028 [A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the cytoplasm. The cytoplasm is all of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.]
Golgi organization GO_0007030 [A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the Golgi apparatus.]
vacuolar transport GO_0007034 [The directed movement of substances into, out of or within a vacuole.]
vacuole organization GO_0007033 [A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a vacuole.]
nucleobase-containing compound catabolic process GO_0034655 [The chemical reactions and pathways resulting in the breakdown of nucleobases, nucleosides, nucleotides and nucleic acids.]